You need to enable JavaScript to run this app.
FDA announces CMC review pilot for drugs with expedited development
Regulatory News
Joanne S. Eglovitch
Biologics/ biosimilars/ vaccines
Chemistry, Manufacturing and Controls (CMC)
North America
Pharmaceuticals